AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (February 8, 2008). doi:10.1152/ajpheart.00945.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/H1716    most recent
00945.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gergs, U.
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gergs, U.
Right arrow Articles by Neumann, J.
Submitted on August 15, 2007
Accepted on February 4, 2008

A positive inotropic effect of ATP in the human cardiac atrium

Ulrich Gergs1, Peter Boknik2, Wilhelm Schmitz2, Andreas Simm3, Rolf Edgar Silber3, and Joachim Neumann1*

1 Institut fur Pharmakologie und Toxikologie, Martin-Luther-Universitat Halle-Wittenberg, Halle (Saale), Germany
2 Pharmacology and Toxicology, University Clinic Muenster, Muenster, Germany
3 Klinik fur Herz- und Thoraxchirugie, Martin-Luther-Universitat Halle-Wittenberg, Halle (Saale), Germany

* To whom correspondence should be addressed. E-mail: joachim.neumann{at}medizin.uni-halle.de.

We studied contractile effects in isolated electrically driven (1Hz) atrial preparations from patients undergoing cardiac bypass surgery. Adensine triphosphate (ATP) concentration-dependently (10, 30, 100 µM) rapidly decreased force of contraction (negative inotropic effect, NIE) and thereafter more slowly increased force of contraction, the maximum positive inotropic effect (PIE) at 100 µM ATP amounted to 152 % of pre-drug value (n=9), was stable and could be washed out fast and completely. The PIE did not affect time parameters of contraction (time to peak tension and time of relaxation). Moreover, a similar NIE and PIE were noted with ATP{gamma}S (100 µM). In contrast 2-methyl-thio-ATP did not exert a NIE but only a PIE. In a second set of experiments, preparations were first incubated for 30 min with purinoreceptor-antagonists and in their continuous presence, 100 µM ATP was applied. However, the PIE as well as the NIE of ATP could neither be blocked with suramin (100 µM and 500 µM) nor PPADS (50 µM) nor reactive blue 2 (30, 100, 500 µM), which are known blocker for subtypes of P2-receptors, or DPCPX (1 and 10 µM), a subtype (A1-adenosine) P1-receptor blocker. Likewise the inhibitor of PLC activity U73122 and the inhibitor of adenylate cyclase activity SQ22563 (10 µM, each) failed to affect the NIE and the PIE of ATP. We tentatively suggest that the PIE of ATP might be mediated via P2X4-like receptors. In summary, we describe a novel biphasic effect of ATP on force contraction in the isolated human atrium. It is conceivable that ATP plays a physiological role in the human heart, for instance after cardiac injury in order to sustain contractility.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Sonin, S.-Y. Zhou, C. Cronin, T. Sonina, J. Wu, K. A. Jacobson, A. Pappano, and B. T. Liang
Role of P2X purinergic receptors in the rescue of ischemic heart failure
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1191 - H1197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.